For magnetic resonance imaging (MRI) of esophageal diseases, we have developed a new contrast-enhancement agent, cellulose-ferric ammonium citrate solution. Using this agent, the esophageal lumen is easily identified. This agent is expected to play a role in the MRI diagnosis of esophageal cancer and to help determine the indications for radical surgery and/or intracavitary irradiation.